NEW RIVER PHARMACEUTICALS INC Business Finance Contracts & Agreements
11 Contracts & Agreements
- Assignment Agreements (3 contracts)
- Credit Agreements (1)
- Indenture Agreements (1)
- Note Agreements (1)
- Purchase Agreements (1)
- Registration Rights Agreements (1)
- Share Agreements (1)
- Underwriting Agreements (1)
- Warrant Agreements (1)
- Calculation of U.S. product profit share for Schedule II Classification (Filed With SEC on October 10, 2006)
- Confirmation of OTC Warrant Transaction, effective July 25, 2006 (Filed With SEC on July 27, 2006)
- Confirmation of OTC Convertible Note Hedge, effective July 25, 2006 (Filed With SEC on July 27, 2006)
- Purchase Agreement, dated as of July 19, 2006, among New River Pharmaceuticals Inc. and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated and W.R. Hambrecht... (Filed With SEC on July 27, 2006)
- Registration Rights Agreement, dated as of July 25, 2006, between New River Pharmaceuticals Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (Filed With SEC on July 27, 2006)
- Indenture related to the Convertible Subordinated Notes, due 2013, dated as of July 25, 2006, between New River Pharmaceuticals Inc. and Wilmington Trust Company, as trustee... (Filed With SEC on July 27, 2006)
- ASSIGNMENT (Filed With SEC on July 16, 2004)
- ASSIGNMENT (Filed With SEC on July 16, 2004)
- ASSIGNMENT (Combined) (Filed With SEC on July 16, 2004)
- NEW RIVER PHARMACEUTICALSINC. 4,200,000 Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on July 16, 2004)
- CREDIT AGREEMENT (Filed With SEC on June 11, 2004)
